Taking this medication will reduce your body weight and if you are overweight/obese, it will therefore reduce your chances of heart attacks, heart disease, stroke and many more weight-related conditions.

Results are usually seen immediately, within first month, as hunger is suppressed by the medication.

Wegovy functions by acting as an agonist of a hormone called glucagon-like peptide-1 (GLP-1). This hormone plays a critical role in regulating appetite and food intake. The GLP-1 hormone is naturally released in your gut when you eat, signaling to your brain that you are full, therefore by imitating GLP-1, Wegovy helps you feel full sooner and reduces your overall hunger, making it easier to stick to a lower calorie diet.

Gradual Dose Increase: To minimize gastrointestinal side effects such as nausea and vomiting, the dosage of Wegovy is gradually increased over time to reduce any chances of irritation from it.

Clinical Trials: The safety and efficacy of Wegovy were studied in four 68-week trials. These trials included more than 2,600 patients who received Wegovy and over 1,500 patients who received a placebo. The trials showed significant weight loss and provided valuable data about the medication’s long-term safety and effectiveness.

Significant Health Benefits

Losing weight isn’t just about looking better; it’s about improving your overall health. Wegovy offers substantial health benefits:

Reduces Risks of Heart Disease: Carrying excess weight increases your risk of heart disease. By helping you lose weight, Wegovy can lower this risk.

Lowers Stroke Risk: Obesity is a major risk factor for stroke. Weight loss achieved through Wegovy can reduce this risk considerably.

Manages Diabetes Risk: Obesity is closely linked to type 2 diabetes. Losing weight can help manage or even prevent this condition.

Impressive Weight Loss Results

The effectiveness of Wegovy is backed by clinical trials:

Non-Diabetic Adults: In studies, non-diabetic adults using Wegovy lost an average of 12.4% of their initial body weight. This is a significant reduction that can lead to better health outcomes.

Adults with Type 2 Diabetes: For those with type 2 diabetes, Wegovy helps reduce body weight by an average of 6.2%. While this is slightly lower than the weight loss in non-diabetic adults, it’s still a meaningful improvement that can aid in diabetes management.

When using Wegovy, weight loss results vary from person to person. However, clinical trials provide some clear insights into what you might expect.

Immediate Results

First Month: On average, patients can lose up to 5% of their initial body weight within the first month. This early drop is often encouraging and can help motivate you to stick with the program.

Two Months: By the end of the second month, the potential weight loss can reach up to 8%. This means if you start at 100kg, you might lose around 8kg in two months.

Key Factors for Success

Weight loss with Wegovy also depends on how well you adhere to lifestyle changes. Here’s what plays a crucial role:

Diet: Following a reduced-calorie diet is essential. Wegovy works best when you combine it with healthier eating habits.

Exercise: Increased physical activity boosts your results. Even small amounts of regular exercise can make a significant difference.

Consistency: Regularly taking your weekly injections helps maintain steady progress. Missing doses can slow down or halt weight loss.

Our Policy on pricing is to be both competitive and transparent and we will always make sure that before you undertake a consultation or a treatment with us that you are fully aware of the prices.